Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

(Radiolabeling techniques using iodine-123)

Technical Report ·
OSTI ID:7043987
The traveler participated in the European Nuclear Medicine Congress in Budapest, Hungary, where he presented a paper describing studies with isolated rat hearts being utilized to isolate and evaluate metabolites formed from radioiodinated fatty acids used as heart imaging agents. He also chaired a technical session on new radiopharmaceuticals and coauthored four other papers describing clinical studies of iodine-123-labeled fatty acids in various patient groups conducted in collaboration with investigators in Bonn and Aachen, West Germany. He also visited the Institute for Clinical and Experimental Nuclear Medicine in Bonn, where he presented a seminar describing new radiolabeling techniques being developed at the Oak Ridge National Laboratory (ORNL) for therapeutic applications. In additions, he planned, discussed and coordinated collaborative studies with colleagues in Bonn. He also visited the Department of Nuclear Medicine at the University of Aachen to discuss collaborative research, write papers and plan future joint studies.
Research Organization:
Oak Ridge National Lab., TN (USA)
Sponsoring Organization:
DOE/ER
DOE Contract Number:
AC05-84OR21400
OSTI ID:
7043987
Report Number(s):
ORNL/FTR-2652; ON: DE90012355
Country of Publication:
United States
Language:
English